Involved pharmaceutical companies in the Oral Mucositis market are Galera Therapeutics, Soligenix, Monopar Therapeutics, Enzychem Lifesciences, Innovation Pharmaceuticals, Spherium Biomed, and others.
DelveInsight’s “Oral Mucositis Pipeline” highlights the details around Oral Mucositis, painful inflammation, and ulceration of the mucous membranes lining the mouth, usually as an adverse effect of chemotherapy and radiotherapy treatment for cancer.
The Oral Mucositis report provides a disease overview, pipeline scenario, and therapeutic assessment of the key pipeline therapies in this domain. The report also highlights the unmet needs concerning the development of Oral Mucositis.
Some of the key highlights of the Oral Mucositis Pipeline report–
Request for Sample @ Oral Mucositis Pipeline Insights
Oral Mucositis is a painful inflammation and ulceration of the mucous membranes lining the mouth, usually as an adverse effect of chemotherapy and radiotherapy treatment for cancer. Mucositis leads to several problems including pain, problems with nutrition and being unable to eat, and a higher chance of infection due to open sores. About 40% of people undergoing regular cancer therapy will get Oral Mucositis.
Oral Mucositis Emerging Therapies: Drug Profile
Cooral is a single-use oral cooling device that links to a portable cooling system and cools the oral mucosa. Cooral is equipped with an ECU200 water cooling unit that circulates 8°C water into an attached mouthpiece which is inserted into the patient’s mouth.
CareMin650 previously ONCORED from NeoMedLight is a device using the light-emitting fabric Lightex – unique patented technology – emitting light through woven optic fibers.
Validive (clonidine Lauriad) is a mucoadhesive tablet based on the Lauriad technology that delivers high concentrations of an anti-inflammatory active principle (clonidine) directly in the oral cavity, the site of irradiation in the treatment of head and neck cancer.
Know More Information @ Oral Mucositis Pipeline Drugs
Key Pipeline Therapies along with companies
By Product Type
By Route of Administration
By Molecule Type
By Mechanism of Action
Contact Here for More Information @ Oral Mucositis Pipeline Assessment
Scope of the Oral Mucositis Pipeline Report
Following is the Table of content of the Oral Mucositis Pipeline Report
|3||Oral Mucositis Current Treatment Patterns|
|4||Oral Mucositis – DelveInsight’s Analytical Perspective|
|6||Oral Mucositis Late Stage Products (Phase-III)|
|7||Oral Mucositis Mid Stage Products (Phase-II)|
|8||Early Stage Products (Phase-I)|
|9||Pre-clinical Products and Discovery Stage Products|
|12||Oral Mucositis Discontinued Products|
|13||Oral Mucositis Product Profiles|
|14||Oral Mucositis Key Companies|
|15||Oral Mucositis Key Products|
|16||Dormant and Discontinued Products|
|17||Oral Mucositis Unmet Needs|
|18||Oral Mucositis Future Perspectives|
|19||Oral Mucositis Analyst Review|
Know more of what’s covered in the Oral Mucositis Pipeline Assessment report
Key Questions Answered in the Oral Mucositis report-
Request for demo @ Oral Mucositis Pipeline and get a walk-through of our report
DelveInsight’ s Cervical Cancer Market Insights, Epidemiology and Market Forecast – 2030 report.
DelveInsight’ s Prostate cancer Market Insights, Epidemiology and Market Forecast – 2030 report.
DelveInsight’s Cancer Anorexia Market Insights, Epidemiology and Market Forecast – 2030 report.
DelveInsight’ s Non-Small Cell Lung Cancer – Market Insights, Epidemiology and Market Forecast – 2030 report.
Visit on our blog section-
DelveInsight is a leading Business Consultant & Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. Get hassle-free access to all the healthcare & pharma market research reports through our subscription-based platform PharmDelve.